Printer Friendly

Browse Vascular endothelial growth factor topic

Articles

1-300 out of 473 article(s) nextnext page
Title Author Type Date Words
Hutchison China MediTech completes patient enrollment in Phase III FALUCA trial. Feb 13, 2018 134
Clinical Data from Taiho Oncology and Servier Study of Lonsurf (trifluridine and tipiracil) in Metastatic Colorectal Cancer Presented at ASCO 2018 Gastrointestinal Cancers Symposium. Jan 24, 2018 436
Aveo Oncology Presents Results of Phase 1b/2 Study of Tivozanib in Patients with Advanced Hepatocellular Carcinoma. Jan 23, 2018 430
Amgen & Allergan's MVASI (Biosimilar Bevacizumab) approved by EC for certain types of cancer. Jan 19, 2018 296
Amgen & Allergan's MVASI (Biosimilar Bevacizumab) approved by EC for certain types of cancer. Jan 19, 2018 300
United Kingdom,United States : Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA (aflibercept). Jan 4, 2018 251
Effects of Hypoxic Training versus Normoxic Training on Exercise Performance in Competitive Swimmers. Park, Hun-Young; Lim, Kiwon Report Dec 1, 2017 7519
Management of neovascular AMD in secondary care. Fulcher, Corinne Dec 1, 2017 3173
Safflower Extract and Aceglutamide Injection Promoting Recovery of Peripheral Innervations via Vascular Endothelial Growth Factor-B Signaling in Diabetic Mice. Li, Dan; Chen, You-Gang; Zhang, Cui-Juan; Tian, Jing; Li, Xia Dec 1, 2017 4524
Regeneron Pharmaceuticals' Phase two studies of eye-drug combination fail to warrant phase three development. Nov 29, 2017 232
Regeneron Pharmaceuticals' Phase two studies of eye-drug combination fail to warrant phase three development. Nov 29, 2017 228
Notal Vision Collaborates with IRIS Registry to Improve Understanding of Visual Acuity in AMD. Nov 13, 2017 276
Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma. Bukhari, Nedal Report Nov 1, 2017 1532
Hutchison China MediTech initiates FRUTIGA Phase III clinical trial of fruquintinib. Oct 31, 2017 220
Hutchison China MediTech initiates FRUTIGA Phase III clinical trial of fruquintinib. Oct 31, 2017 216
X4 Pharmaceuticals Completes Dose Escalation Portion of Clinical Trial of X4P-001-IO in Combination with Inlyta (Axitinib) in Patients with Clear Cell Renal Cell Carcinoma. Oct 31, 2017 348
Chi-Med reveals preliminary Phase II data for fruquintinib combination. Oct 16, 2017 187
Choroidal Neovascularization - Pipeline Review, H2 2017. Oct 11, 2017 777
Biologica Technologies showcases AMP aesthetic(TM) at Plastic Surgery The Meeting 2017. Oct 6, 2017 327
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2017. Sep 18, 2017 804
X4 Pharmaceuticals to Present Data from Study of X4P-001-IO and Inlyta (axitinib) Combination at European Society of Medical Oncology 2017 Congress. Sep 1, 2017 242
Germany : Bayer to showcase latest Ophthalmology research at EURETINA 2017. Sep 1, 2017 661
Outcomes of Intravitreal Dexamethasone Implant in the Treatment of Recalcitrant Diabetic Macular Edema. Akincioglu, Dorukcan; Kucukevcilioglu, Murat; Durukan, Ali Hakan; Aykaws, Seckin; Ayyildiz, Onder; E Clinical report Sep 1, 2017 3091
Development of VEGF-loaded PLGA matrices in association with mesenchymal stem cells for tissue engineering. Rosa, A.R.; Steffens, D.; Santi, B.; Quintiliano, K.; Steffen, N.; Pilger, D.A.; Pranke, P. Sep 1, 2017 7845
RETINAL NERVE FIBER LAYER THICKNESS IN GLAUCOMA PATIENTS TREATED WITH MULTIPLE INTRAVITREAL ANTL-VEGF (BEVACIZUMAB) INJECTIONS. Kopic, Andrijana; Biuk, Dubravka; Barac, Josip; Vinkovic, Maja; Benasic, Tvrtka; Kopic, Vlatko Report Sep 1, 2017 4633
Content of markers of respiratory tract remodeling in exhaled breath condensate in children suffering from bronchial asthma. Koloskova, Olena; Bilous, Tetiana; Bilyk, Galyna; Lobanova, Tetiana; Dikal, Mariana; Bilous, Volodym Sep 1, 2017 2596
Endocan Measurement for Active Behcet Disease. Kul, Ayhan; Ates, Orhan; Melikoglu, Meltem Alkan; Ugur, Mahir; Ozturk, Nurinnisa; Erkayhan, Gulsum; Sep 1, 2017 3243
AVEO Oncology's Fotivda (tivozanib) Approved in the European Union, Norway, and Iceland for Treatment of Advanced Renal Cell Carcinoma. Aug 29, 2017 330
Antibody Target, Technology & Pipeline Database 2017. Aug 16, 2017 775
Antibody Target, Technology & Pipeline Database 2017. Aug 16, 2017 809
Ophthotech fails to meet primary endpoint in phase three Fovista trial. Aug 15, 2017 197
Ophthotech fails to meet primary endpoint in phase three Fovista trial. Aug 15, 2017 193
Allegro Ophthalmics' Luminate integrin peptide therapy passes phase two trial. Aug 11, 2017 235
Allegro Ophthalmics DEL MAR Study of Luminate as Sequential Therapy in Patients with Diabetic Macular Edema Meets Primary Endpoint. Aug 10, 2017 387
Vitreoretinal cases. McArthur, Craig Aug 1, 2017 552
Transforming Growth Factor-beta 1 Involved in the Pathogenesis of Endometriosis through Regulating Expression of Vascular Endothelial Growth Factor under Hypoxia. Yu, Yue-Xin; Xiu, Yin-Ling; Chen, Xi; Li, Ya-Li Report Jul 27, 2017 5843
Eylea Will Dominate The Wet Age-Related Macular Degeneration Market Until 2018, When Its Share Will Become Threatened By Emerging Products. Jul 19, 2017 809
Internal Medicine. Jul 1, 2017 262
Elevated Levels of Serum Vascular Endothelial Growth Factor-A Are Not Related to NK Cell Parameters in Recurrent IVF Failure. Bansal, Rhea; Ford, Brian; Bhaskaran, Shree; Thum, Meenyau; Bansal, Amolak Report Jul 1, 2017 5006
Undiagnosed mental illness in wet AMD patients. Powell, Selina Clinical report Jun 1, 2017 218
A Novel Use of Area Under the Curve Analysis as an Outcome Measure in the Assessment of a Continuous Microdosing Fluocinolone Acetonide Implant (ILUVIEN) - touchOPHTHALMOLOGY. May 4, 2017 659
A Novel Use of Area Under the Curve Analysis as an Outcome Measure in the Assessment of a Continuous Microdosing Fluocinolone Acetonide Implant (ILUVIEN) - touchOPHTHALMOLOGY. May 4, 2017 663
Stainwei Granted US Patent for anti-VEGF Monoclonal Antibody and its anti-PD-1 mAb demonstrating prolonged anti-tumor activity in pre-clinical studies. Clinical report May 3, 2017 760
Stainwei Granted US Patent for anti-VEGF Monoclonal Antibody and its anti-PD-1 mAb demonstrating prolonged anti-tumor activity in pre-clinical studies. Clinical report May 3, 2017 771
Effects of siRNA-mediated HIF-1a gene silencing on angiogenesis in osteosarcoma. Apr 30, 2017 2101
Histologic correlation of VEGF and COX-2 expression with tumor size in squamous cell carcinoma of the larynx and hypopharynx. Bonhin, Rodrigo Gonzalez; de Carvalho, Guilherme Machado; Guimaraes, Alexandre Caixeta; Rocha, Vanes Report Apr 1, 2017 2631
O24: Interrogating the role of angiogenesis genes on musculoskeletal soft tissue injury risk. Rahim, M.; Saunders, C.J.; Gibbon, A.; Ly, Khoury El; Raleigh, S.M.; Ribbans, W.J.; Posthumus, M.; G Report Mar 22, 2017 109
Yrogenex Completes Patient Enrollment in Phase 2 Trial of Orally Administered Vorolanib. Clinical report Mar 13, 2017 254
Diabetic macular edema: Traditional and novel treatment. Tomic, Martina; Vrabec, Romano; Poljicanin, Tamara; Ljubic, Spomenka; Duvnjak, Lea Report Mar 1, 2017 6279
Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats. Vogl, Thomas Josef; Qian, Jun; Tran, Andreas; Oppermann, Elsie; Naguib, Nagy N.; Korkusuz, Huedayi; Mar 1, 2017 4002
PHARMABCINE COLLABORATES WITH MSD ON CLINICAL EVAL. Feb 1, 2017 677
Exelixis & Takeda partnership to commercialise and develop novel cancer therapy cabozantinib in Japan. Jan 31, 2017 313
Exelixis & Takeda partnership to commercialise and develop novel cancer therapy cabozantinib in Japan. Jan 31, 2017 309
Topical binahong (Anredera cordifolia) leaf extract increases Interleukin-6 and VEGF (vascular endothelial growth factor) during burn wound healing in wistar rats infected with Pseudomonas aeruginosa. Sukrama, Dewa Made; Wihandani, Desak Made; Manuaba, Amertha Putra Report Jan 1, 2017 4139
Correlation of Vascular Endothelial Growth Factor Production with Photochemical Reaction-induced Retinal Edema. Shan, Liang; Zheng, Mi; Zhang, Yuan; Qu, Yuan; Niu, Tian; Gu, Qing; Liu, Kun; Xia, Xin Report Dec 20, 2016 4192
Ophthotech reports disappointing results from Pivotal Phase 3 trials of Fovista in wet age macular degeneration patients. Clinical report Dec 12, 2016 328
Ophthotech reports disappointing results from Pivotal Phase 3 trials of Fovista in wet age macular degeneration patients. Clinical report Dec 12, 2016 324
Amgen and Allergan submit Marketing Authorisation Application to European Medicines Agency for ABP 215. Dec 6, 2016 170
Amgen and Allergan submit Marketing Authorisation Application to European Medicines Agency for ABP 215. Dec 6, 2016 166
Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity. Li, Xiu-Juan; Yang, Xiao-Peng; Sun, Shuang; Lyu, Xiao-Bei; Jia, Heng Report Dec 5, 2016 1608
Sindrome PAGOD y anomalias vasculares: ?es un defecto de la angiogenesis embrionaria? Un nuevo caso y revision. Delgado-Luengo, Wilmer; Jeitas-Cabello, Herminia F.; Solis-Anez, Ernesto; Hernandez-Rodriguez, Maria Dec 1, 2016 5630
United States : Athenex, Lilly partner in phase 1b study of oraxol. Nov 21, 2016 210
MicroRNA-210 Plays a Critical Role in the Angiogenic Effect of Isoprenaline on Human Umbilical Vein Endothelial Cells via Regulation of Noncoding RNAs. Yan, You-You; Wang, Zhi-Hui; Zhao, Lei; Song, Dan-Dan; Qi, Chao; Liu, Lu-Lu; Wang, Jun-Nan Nov 20, 2016 4002
United States : Athenex and Lilly Enter Clinical Collaboration Agreement. Nov 19, 2016 298
Athenex and Lilly Enter Clinical Collaboration Agreement. Nov 18, 2016 1111
Bayer Submits Supplemental New Drug Application for Stivarga (regorafenib) for Advanced Liver Cancer. Nov 7, 2016 4000
amcure announces initiation and first patient treated in a Phase I/Ib clinical study of AMC303 for cancer treatment. Clinical report Oct 27, 2016 314
amcure announces initiation and first patient treated in a Phase I/Ib clinical study of AMC303 for cancer treatment. Clinical report Oct 27, 2016 310
US FDA Clears Genentech's Lucentis (Ranibizumab Injection) Prefilled Syringe. Oct 18, 2016 624
People with Advanced Renal Cell Carcinoma in Sweden, Norway, Denmark and Finland Now Able to Benefit from Kisplyx (Lenvatinib) in Combination with everolimus. Oct 17, 2016 1364
United States : FDA Approves Genentechs Lucentis (Ranibizumab Injection) Prefilled Syringe. Oct 15, 2016 247
Lilly Highlights Advancements in its Oncology Portfolio with New Data at ESMO 2016. Oct 5, 2016 1734
Current concepts in the pathogenesis and management of vascular lesions--a brief review. Sarangi, Snehanjan; Mukherjee, Debanjali Report Oct 1, 2016 3614
Japan,United Kingdom : Eisai receives license for new indication for anticancer agent Kisplyx(LENVATINIB MESYLATE) for treatment of advanced renal cell. Sep 19, 2016 549
Eisai Receives License for New Indication for Anticancer Agent Kisplyx (Lenvatinib Mesylate) for Treatment of Advanced Renal Cell Carcinoma. Clinical report Sep 15, 2016 1466
European Commission Grants Marketing Authorisation for Kisplyx ,u- (Lenvatinib) in Combination with Everolimus in Advanced Renal Cell Carcinoma. Sep 14, 2016 1268
Procurement Of Aflibercept And Ranibizumab ( Anti-vegf ) On The Requisition In 2017 , Sll450 , The Stockholm County Council And Region Gotland . Sep 14, 2016 128
Allergan Showcases Commitment to Eye Care Innovation with New Data Presentations at the Retina Society 49th Annual Scientific Meeting in San Diego. Sep 13, 2016 756
Vascular Endothelial Growth Factor and Cluster of Differentiation 34 for Assessment of Perioperative Bleeding Risk in Gastric Cancer Patients. He, Mu-Qing; He, Mu-Qun; Wang, Jian-Feng; Zhu, Bao-Ling; Sun, Ni; Zhou, Xiao-Hai; Yao, Rong-Xin Report Aug 20, 2016 2808
United Kingdom : AstraZeneca files first clinical trial application in Moderna messenger RNA collaboration. Jul 27, 2016 385
United Kingdom : Two new medicines for advanced kidney cancer. Jul 23, 2016 699
Kisplyx (lenvatinib) in Combination with everolimus Receives Positive CHMP Opinion in Advanced Renal Cell Carcinoma. Jul 22, 2016 1697
Eisai Receives Positive CHMP Opinion on New Indication for Anticancer Agent Lenvatinib in Combination with Everolimus for Treatment of Advanced Renal Cell Carcinoma. Jul 22, 2016 1275
STRONG: European Consortium for the Study of a Topical Treatment of iCRVO to prevent Neovascular Glaucoma. Jul 21, 2016 474
Retinal Diseases: Wet and Dry AMD, Diabetic Retinopathy Market 2016-2026: Aflibercept, Ranibizumab, Bevacizumab, Verteporfin, Ocriplasmin, Anti-VEGF, Anti-PDGF. Jul 18, 2016 4277
Retinal Diseases: Wet and Dry AMD, Diabetic Retinopathy Market 2016-2026: Aflibercept, Ranibizumab, Bevacizumab, Verteporfin, Ocriplasmin, Anti-VEGF, Anti-PDGF. Jul 18, 2016 4282
Visual acuity losses during ongoing anti-VEGF injections. Brief article Jul 1, 2016 286
Germany: Role of Angiogenic Factors in Neurodevelopment. Jun 28, 2016 296
Mutated Gene Influencing Metastatic Colorectal Cancer Survival Rate, According to PiscoMed's Journal AMOR. Jun 3, 2016 822
Novartis announces US collaboration to co-promote Lenvima in combination with everolimus for advanced renal cell carcinoma (RCC). Jun 2, 2016 4304
Three cures in one. Brief article Jun 1, 2016 116
Japan : Anti-Cancer Agent Avastin, Obtained Approval for Additional Indication of Advanced or Recurrent Cervical Cancer. May 24, 2016 290
Austria : Evercyte GmbH, VTU Technology partner to develop recombinant media supplements. May 24, 2016 290
ASCO Data Underscore Lilly's Diverse Oncology Pipeline and Portfolio. May 18, 2016 1600
Alimera Sciences' ILUVIEN Data Presented At 2016 ARVO. May 6, 2016 925
Pluristem to acquire rights for placental cell therapy patent. May 2, 2016 371
Pluristem to acquire rights for placental cell therapy patent. May 2, 2016 371
Study Proves Long-Term Effectiveness of Avastin and Lucentis for Treating Major Cause of Blindness. May 2, 2016 1150
Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy. Song, Yan; Du, Chun-Xia; Zhang, Wen; Sun, Yong-Kun; Yang, Lin; Cui, Cheng-Xu; Chi, Yihe-Bali; Shou, Report May 1, 2016 3152
Impacts of N-Butylphthalide on expression of growth factors in rats with focal cerebral ischemia. Jiang, Yan; Sun, Leyu; Xuan, Xiaoyan; Wang, Jianping May 1, 2016 3711
Taiho Pharmaceutical receives marketing authorisation for Lonsurf from European Commission. Apr 29, 2016 168
Taiho Pharmaceutical receives marketing authorisation for Lonsurf from European Commission. Apr 29, 2016 164
New Preclinical Data Show Combination of Lenvatinib and Everolimus Yield Greater Antitumor Activity Than Either Agent Alone in Kidney Cancer. Apr 19, 2016 2284
Germany,United States : Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA in Renal Cell Carcinoma. Apr 7, 2016 498
Germany,United States : Merck and Pfizer announce first Patient treated in Phase III Combination Study with Avelumab and INLYTA in Renal Cell Carcinom. Apr 6, 2016 546
Regeneron and Bayer partnership to develop novel combination therapy for eye diseases. Mar 25, 2016 227
Regeneron and Bayer partnership to develop novel combination therapy for eye diseases. Mar 25, 2016 223
Germany,United States : Bayer and Regeneron To Jointly Develop Novel Combination Therapy for Eye Diseases. Mar 25, 2016 443
Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases. Mar 24, 2016 1549
Nerve Growth Factor Promotes Angiogenesis and Skeletal Muscle Fiber Remodeling in a Murine Model of Hindlimb Ischemia. Diao, Yong-Peng; Cui, Feng-Kui; Yan, Sheng; Chen, Zuo-Guan; Lian, Li-Shan; Guo, Li-Long; Li, Yong-Ju Report Mar 1, 2016 4104
CHMP Issues Positive Opinion for LONSURF(R) (trifluridine/tipiracil) for Refractory Metastatic Colorectal Cancer. Feb 29, 2016 1865
Tyrogenex to Present at the Landmark Venture Forum at the Boca Raton Resort and Club - Boca Raton, FL. Feb 19, 2016 628
Tyrogenex to Present at 18th Annual BIO CEO & Investor Conference(TM). Conference news Feb 3, 2016 621
Pravastatin induces cell cycle arrest and decreased production of VEGF and bFGF in multiple myeloma cell line/Pravastatina induz parada no ciclo celular e diminuicao na producao de VEGF e bFGF em linhagem de Mieloma Multiplo. Trojan, P.J.J.; Bohatch, M.S., Jr.; Otuki, M.F.; Souza-Fomeca-Guimaraes, F.; Svidnicki, P.V.; Nogaro Feb 1, 2016 3467
Preclinical Alzheimer's disease data published. Jan 18, 2016 249
Eisai's Lenvatinib Receives FDA Priority Review for the Potential Treatment of Advanced Renal Cell Carcinoma in Combination with Everolimus. Jan 17, 2016 2061
Alzheimer's disease data published. Jan 11, 2016 245
Alzheimer's disease data published. Jan 11, 2016 245
Neuralstem's Preclinical Alzheimer's Disease Data Published In Stem Cells Translational Medicine. Jan 11, 2016 956
New Application of Lenvatinib in Combination with Everolimus for Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC) Submitted to the European Medicines Agency (EMA) by Eisai. Jan 11, 2016 1563
Tyrogenex to Present at 8th Annual Biotech Showcase(TM). Jan 4, 2016 720
Alterations of Thymic Epithelial Cells in Lipopolysaccharide-induced Neonatal Thymus Involution. Zhou, Yong-Jie; Peng, Hua; Chen, Yan; Liu, Ya-Lan Report Jan 1, 2016 3876
Treatment outcomes in patients with polypoidal choroidal vasculopathy. Muslubas, Isil Sayman; Hocaoglu, Mumin; Arf, Serra; Ozdemir, Hakan; Karacorlu, Murat Report Jan 1, 2016 2907
Cloning and optimization of soluble vascular endothelial growth [Factor.sub.165] expression in Escherichia coli. Salimi, Ali; Babashamsi, Mohammad Report Jan 1, 2016 3896
Initiation of Fruquintinib Phase III Registration Trial in Non-small Cell Lung Cancer. Dec 8, 2015 1247
Effect of Hyperbaric Oxygen on the Growth of Intracranial Glioma in Rats. Ding, Jian-Bo; Chen, Jun-Rui; Xu, Hong-Zhi; Qin, Zhi-Yong Report Dec 5, 2015 4621
Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2. Garcia, Jesus R.; Gombos, Dan S.; Prospero, Claudia M.; Ganapathy, Aravindh; Penland, Rebecca L.; Ch Dec 1, 2015 5748
Ophthalmology's Data Science Initiative Yields Important Insights on Rare Complications of Common Eye Procedures. Nov 14, 2015 1531
Allergan Presents EARLY Analysis Data at the American Academy of Ophthalmology (AAO) Annual Meeting. Nov 13, 2015 1277
Tyrogenex Presents Final Results from Phase 1 Study of X-82 for Wet AMD at the 2015 Annual American Academy of Ophthalmology Meeting. Nov 13, 2015 776
Allergan Presents Data at the 2015 American Academy of Ophthalmology (AAO) Annual Meeting in Las Vegas. Nov 12, 2015 850
Leading Ophthalmologists Highlight the Importance of Illuvien for Chronic DME in the First US Review After the Long Awaited FDA Approval. Nov 5, 2015 427
Leading Ophthalmologists Highlight the Importance of Illuvien for Chronic DME in the First US Review After the Long Awaited FDA Approval. Nov 5, 2015 446
Regeneron passes EU approval for EYLEA Injection for the treatment of myopic CNV. Nov 2, 2015 232
Regeneron passes EU approval for EYLEA Injection for the treatment of myopic CNV. Nov 2, 2015 228
Biologica Technologies showcasing Allofill(TM) at the annual American Society of Plastic Surgeons meeting. Oct 16, 2015 424
New Review of Low-energy Stereotactic Radiotherapy for Treatment of Exudative Age-related Macular Degeneration Adjunctive to Anti-VEGF Therapy. Oct 15, 2015 501
New Review of Low-energy Stereotactic Radiotherapy for Treatment of Exudative Age-related Macular Degeneration Adjunctive to Anti-VEGF Therapy. Oct 15, 2015 506
Lenvatinib Phase II Results Published in The Lancet Oncology Show Significant Improvement in Progression-Free Survival When Used With Everolimus in Metastatic Renal Cell Carcinoma. Oct 15, 2015 1596
Diplomat to Dispense Taiho Drug, LONSURF (trifluridine and tipiracil). Oct 12, 2015 1814
Screening Test Predicts Poor Treatment Response in Metastatic Kidney Cancer. Sep 30, 2015 1016
Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF [sub]165 b Isoform in the Vitreous of Patients with Retinopathy of Prematurity. Zhao, Min; Xie, Wan-Kun; Bai, Yu-Jing; Huang, Lyu-Zhen; Wang, Bin; Liang, Jian-Hong; Yin, Hong; Li, Report Sep 20, 2015 3331
Fruquintinib Phase II Clinical Results in Colorectal Cancer to be Presented at the 2015 European Cancer Congress. Sep 14, 2015 1167
RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Ocular Indications. Sep 8, 2015 973
Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study. Sep 2, 2015 989
Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder. Aug 31, 2015 3821
Macular degeneration: emerging treatments and a changing research landscape. O'Hare, Ryan Brief article Aug 8, 2015 314
Real-world anti-VEGF results: Br J Ophthalmol (bit.ly/IIslZSU). O'Hare, Ryan Brief article Aug 8, 2015 283
Analyses of Potential Predictive Markers and Response to Targeted Therapy in Patients with Advanced Clear-cell Renal Cell Carcinoma. Song, Yan; Huang, Jing; Shan, Ling; Zhang, Hong-Tu Report Aug 5, 2015 4317
Tongxinluo Inhibits Cyclooxygenase-2, Inducible Nitric Oxide Synthase, Hypoxia-inducible Factor-2a/Vascular Endothelial Growth Factor to Antagonize Injury in Hypoxia-stimulated Cardiac Microvascular Endothelial Cells. Li, Yan-Ning; Wang, Xiu-Juan; Li, Bin; Liu, Kun; Qi, Jin-Sheng; Liu, Bing-Hui; Tian, Ye Report Aug 1, 2015 3627
Metastatic renal cell cancer: summary from ASCO 2015. Conference notes Aug 1, 2015 2447
Therapeutic potential of mesenchymal stem cells in the treatment of gastric ulcer. Rashed, Laila; Fayez, Salwa Report Aug 1, 2015 3063
FDA Grants Breakthrough Therapy Designation to Eisai's Lenvatinib for the Potential Treatment of Metastatic Renal Cell Carcinoma. Jul 28, 2015 2024
Positive Results of Clinical Trials - Report on TRACON Pharmaceuticals. Report Jul 22, 2015 1092
A New Discovery: Successful Cancer & HIV+ Reversal Method Through DNA Repair, Gene Expression Modulation & Simplified Immunomodulation Therapeutics Available & Will Exceed US$100 Billion by 2019. Jul 20, 2015 616
Global Diabetic Retinopathy Market 2015-2019. Jun 22, 2015 1169
Global Diabetic Retinopathy Market 2015-2019. Jun 22, 2015 1175
AMD_CNV_HIF: Investigating the role of HIFs in myeloid cells during experimental choroidal neovascularisation. Jun 9, 2015 260
Casi Pharmaceuticals files application with China's Food and Drug Administration for approval of ENMD-2076. Jun 8, 2015 185
Casi Pharmaceuticals files application with China's Food and Drug Administration for approval of ENMD-2076. Jun 8, 2015 181
RXi Pharmaceuticals awarded USPTO's Notice of Allowance for RXI-109 for use in the eye. Jun 4, 2015 196
RXi Pharmaceuticals awarded USPTO's Notice of Allowance for RXI-109 for use in the eye. Jun 4, 2015 192
RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye. Jun 3, 2015 945
Look to green tea and apples for health benefits. Jun 1, 2015 119
What's new in renal cell cancer research? Highlights of GU-ASCO 2015. Conference notes Jun 1, 2015 824
Lilly partners with AstraZeneca on immuno-oncology combination clinical trial in solid tumors. Jun 1, 2015 243
"Global Diabetic Retinopathy Market 2015-2019 " is now available at Fast Market Research. May 25, 2015 557
Lpath Reports Results for iSONEP(TM) in Patients with Wet Age-related Macular Degeneration. Clinical report May 20, 2015 1252
TRACON wins US FDA's fast track designation for TRC105 for treating advanced renal cell carcinoma. May 15, 2015 222
TRACON wins US FDA's fast track designation for TRC105 for treating advanced renal cell carcinoma. May 15, 2015 218
Chi-Med Announces Positive Fruquintinib Proof-of-concept Study Results Trigger Payments From Lilly. May 13, 2015 577
HUTCHISON MEDIPHARMA RECEIVES US$18 MILLION IN PAYMENTS. May 1, 2015 904
Clinical significance of COX-2, GLUT-1 and VEGF expressions in endometrial cancer tissues. Apr 30, 2015 3366
Apoptosis and inflammation form the mystery of pathogenesis of diabetic retinopathy. Mondal, Lakshmi Kanta; Biswas, Debasis; Samaddar, Sandip; Bhaduri, Gautam; Choudhari, Subhadip Report Apr 2, 2015 3377
Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): case report and review of the literature. de Velasco, Guillermo; Munoz, Cesar; Sepulveda, Juan M.; Castellano, Daniel Case study Apr 1, 2015 2140
Eisai's UK subsidiary received positive opinion for Lenvima. Mar 31, 2015 150
Eisai's UK subsidiary received positive opinion for Lenvima. Mar 31, 2015 146
Neurotech Announces FDA Acceptance of Investigational New Drug Application and Clinical Trial Initiation of Novel Therapy for Wet AMD. Clinical report Mar 30, 2015 863
Lpath Reports Results for ASONEP Phase 2a Study in Renal Cell Carcinoma. Mar 24, 2015 1258
U.S. patents for matrix biomaterial. Mar 9, 2015 112
U.S. patents for matrix biomaterial. Mar 9, 2015 111
CorMatrix Cardiovascular Issued 12 Additional US Patents. Mar 5, 2015 235
Eisai's US subsidiary launches Lenvima in US. Mar 4, 2015 184
Eisai's US subsidiary launches Lenvima in US. Mar 4, 2015 180
Triphase Accelerator signs academic centre collaboration with Sunnybrook Research Institute. Mar 2, 2015 170
Triphase Accelerator signs academic centre collaboration with Sunnybrook Research Institute. Mar 2, 2015 166
Diagnostic Values of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor for Benign and Malignant Hydrothorax. Gu, Yan; Zhang, Min; Li, Guo-Hua; Gao, Jun-Zhen; Guo, Liping; Qiao, Xiao-Juan; Wang, Li-Hong; He, La Report Mar 1, 2015 3349
NIH-Sponsored Comparative Effectiveness Trial in Diabetic Macular Edema Shows EYLEA (aflibercept) Injection Demonstrated Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab. Feb 18, 2015 2587
Genentech receives approval from US Food and Drug Administration for Lucentis. Feb 10, 2015 137
Genentech receives approval from US Food and Drug Administration for Lucentis. Feb 10, 2015 133
Pfenex And Hospira Announce Collaboration To Develop And Commercialize Proposed LUCENTIS Biosimilar. Feb 10, 2015 1200
Eisai's Phase II Trial of Anticancer Agent Lenvatinib in Renal Cell Carcinoma Meets Primary Endpoint. Feb 2, 2015 1098
Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview. Jan 29, 2015 536
Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview. Jan 29, 2015 563
3SBio Signs Exclusive Patent License Agreement for DIG-KT, a Bi-Specific mAb targeting VEGFR2 and Tie-2 with PharmAbcine. Jan 14, 2015 1678
Expression patterns of VEGF and Flk-1 in human endometrium during the menstrual cycle. Lai, Tsung-Hsuan; Vlahos, Nikos; Shih, Ie-Ming; Zhao, Yulian Report Jan 1, 2015 3907
Association between the functional polymorphism of vascular endothelial growth factor gene and breast cancer: a meta-analysis. Li, Juan; Ju, Yongjian Report Jan 1, 2015 6792
Ocular Disorders Market 2014: Rising Therapeutics, Technologies, and Devices. Dec 15, 2014 1133
Ocular Disorders Market 2014: Rising Therapeutics, Technologies, and Devices. Dec 15, 2014 1137
Market Report, "Physician Views: Biosimilar Lucentis - what opportunity?", published. Dec 14, 2014 405
Lpath Completes Enrollment in its Phase 2 Clinical Trial of iSONEP for Wet Age-Related Macular Degeneration. Dec 2, 2014 1093
Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib. Richter, Suzanne; Seah, Jo-An; Pond, Gregory R.; Gan, Hui K.; Mackenzie, Mary J.; Hotte, Sebastien J Report Dec 1, 2014 3357
Global Oncology Market to hit $109 billion - Spotlight on Drug Life Cycle Management, M&A and Pipeline Strategies. Nov 19, 2014 1150
Global Oncology Market to hit $109 billion - Spotlight on Drug Life Cycle Management, M&A and Pipeline Strategies. Nov 19, 2014 1154
3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine. Nov 18, 2014 1467
ALTANGIOTARGET: Understanding tumour resistance: Receptors and signalling pathways that can lead the race against tumour angiogenesis. Nov 13, 2014 328
Blood vessel protein could help treat prostate tumours: Study. Nov 12, 2014 218
OncoMed gets US patent for anti-DLL4/anti-VEGF bispecific antibody. Nov 4, 2014 259
OncoMed Pharmaceuticals wins anti-DLL4/Anti-VEGF bispecific antibody patent in the US. Nov 4, 2014 158
OncoMed Pharmaceuticals wins anti-DLL4/Anti-VEGF bispecific antibody patent in the US. Nov 4, 2014 154
Increased Scrutiny by EU5 Health Authorities Will Encourage Use of Off-label Avastin and Emerging Biosimilars in the European Wet Age-Related Macular Degeneration Market. Nov 4, 2014 668
Polymorphisms of vascular endothelial growth factor on prognosis in osteosarcoma patients. Clinical report Oct 31, 2014 3553
Investigation of VEGF-C involvement in acquired metastatic properties of renal cell carcinoma following anti-angiogenesis treatments. Oct 31, 2014 317
Physician-Reported Patient Share for Bayer's Eylea in the EU5 Wet Age-Related Macular Degeneration Market Has Increased Significantly Over the Past Year. Oct 27, 2014 741
Choroidal neovascular membrane. Lanier, Kate Oct 17, 2014 2893
Medical discovery first step on path to new painkillers. Oct 3, 2014 152
New insights into VEGF-A alternative splicing: key regulatory switching in the pathological process. Dehghanian, Fariba; Hojati, Zohreh; Kay, Maryam Report Oct 1, 2014 3786
Choroidal neo-vascularization presentation in younger age group (pre-senile). Sep 30, 2014 1287
Ophthalmic drug updates. Brief article Sep 19, 2014 282
Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD. Sep 18, 2014 686
Regeneron Pharmaceuticals applies marketing authorisation application for EYLEA Injection for macular edema following BRVO in Japan. Sep 4, 2014 220
Regeneron Pharmaceuticals applies marketing authorisation application for EYLEA Injection for macular edema following BRVO in Japan. Sep 4, 2014 216
Recombinant goat VEGF164 increases hair growth by painting process on the skin of shaved mouse. Bao, Wenlei; Yin, Jianxin; Liang, Yan; Guo, Zhixin; Wang, Yanfeng; Liu, Dongjun; Wang, Xiao; Wang, Z Report Sep 1, 2014 3069
Altitude training at sea level and its impact on EPO and VEGF. Mikulski, Tomasz; Dabrowski, Jan; Krzywanski, Jaroslaw Report Sep 1, 2014 2710
Study shows calprotectin, hs-CRP are serum biomarkers for clinical response in PoC spondyloarthritis studies. Aug 19, 2014 204
Physician-Reported Patient Share for Regeneron's Eylea Has Now Stabilized Following Significant Increases after Its U.S. Launch for Wet Age-Related Macular Degeneration. Aug 14, 2014 697
Regeneron Pharmaceuticals wins EU approval to market EYLEA Injection for Diabetic Macular Edema. Aug 11, 2014 186
Regeneron Pharmaceuticals wins EU approval to market EYLEA Injection for Diabetic Macular Edema. Aug 11, 2014 182
Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP. Jul 24, 2014 1210
Global Macular Edema Market 2014-2018. Jul 22, 2014 1323
Study shows VEGFR-3, CXCR4 are predictive biomarkers for FLO, FLP therapy in advanced oesophagogastric cancer. Jul 1, 2014 286
Vascular Endothelial Growth Factor expression in peripheral blood of patients with pregnancy induced hypertension syndrome and its clinical significance. Report Jun 30, 2014 2663
Polimorfismo en el gen del factor de crecimiento vascular endotelial (VEGF) y su asociacion con la preeclampsia. Pacheco-Romero, Jose; Huerta, Doris; Acosta, Oscar; Cabrera, Santiago; Vargas, Marlene Jun 22, 2014 3455
Gastroprotective effect of epoxy clerodane diterpene isolated from Tinospora cordifolia miers (guduchi) on indomethacin-induced gastric ulcer in rats. Antonisamy, Paulrayer; Dhanasekaran, Muniyappan; Ignacimuthu, Savarimuthu; Duraipandiyan, Veeramuthu Report Jun 15, 2014 2686
Cancer drug hope for eye diseases. Brief article Jun 6, 2014 106
Prior to Anticipated Approval, Regeneron's Eylea Prescriber Base Has Increased Significantly in Diabetic Macular Edema Compared with 12 Months Ago. May 7, 2014 698
Molecular characterization and expression analysis of equine vascular endothelial growth factor alpha (VEGF[alpha]) gene in horse (Equus caballus). Songa, Ki-Duk; Cho, Hyun-Woo; Lee, Hak-Kyo; Cho, Byung Wook Report May 1, 2014 3344
PANOPTICA RAISES $45 MILLION FOR CLINICAL DEVELOPMENT. May 1, 2014 1023
Effect of low-intensity direct current on expression of vascular endothelial growth factor and nitric oxide in diabetic foot ulcers. Mohajeri-Tehrani, Reza; Nasiripoor, Faezeh; Torkaman, Giti; Hedayati, Mehdi; Annabestani, Zohreh; As May 1, 2014 5905
Additional U.S. patent for stem cell technology. Apr 21, 2014 137
Additional U.S. patent for stem cell technology. Apr 21, 2014 137
Investigation Report on China Bevacizumab Market, 2009-2018. Mar 24, 2014 621
Analysis of the US Retinal Therapeutics Market. Mar 24, 2014 1319
Investigation Report on China Bevacizumab Market, 2009-2018. Mar 24, 2014 627
Santen and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology. Mar 4, 2014 885
Germany : Bayer Submits VEGF Trap-Eye (aflibercept solution for injection) for Treatment of Diabetic Macular Edema in Japan. Mar 4, 2014 437
VEGF and bFGF expression and histological characteristics of the bone-tendon junction during acute injury healing. Wang, Lin; Gao, Weiwei; Xiong, Kaiyu; Hu, Kuan; Liu, Xincun; He, Hui Report Mar 1, 2014 5343
The effects of nitrous oxide on vascular endothelial growth factor (VEGF) and its soluble receptor 1 (VEGFR1) in patient undergoing urological surgery. Feb 28, 2014 2938
Novartis receives approval for Lucentis from Japanese regulatory bodies. Feb 25, 2014 122
Novartis receives approval for Lucentis from Japanese regulatory bodies. Feb 25, 2014 118
AVEO Oncology & Astellas Pharma Inc to terminate worldwide collaboration & license agreement for tivozanib and discontinue Phase 2 BATON study for colorectal cancer. Feb 17, 2014 177
AVEO Oncology & Astellas Pharma Inc to terminate worldwide collaboration & license agreement for tivozanib and discontinue Phase 2 BATON study for colorectal cancer. Feb 17, 2014 173
VEGF-A levels in pancreatic fluid can distinguish serous cystic neoplasms, pancreatic cysts - report. Feb 14, 2014 343
PharmaPoint: Microvascular Complications of Diabetes - US Drug Forecast and Market Analysis to 2022. Industry overview Feb 14, 2014 474
PharmaPoint: Microvascular Complications of Diabetes - UK Drug Forecast and Market Analysis to 2022. Industry overview Feb 12, 2014 1509
Bayer HealthCare and Regeneron report positive two-year results from Phase III VISTA-DME trial of VEGF Trap-Eye. Feb 12, 2014 148
Bayer HealthCare and Regeneron report positive two-year results from Phase III VISTA-DME trial of VEGF Trap-Eye. Feb 12, 2014 144
PharmaPoint: Microvascular Complications of Diabetes - UK Drug Forecast and Market Analysis to 2022. Industry overview Feb 10, 2014 475
Germany : Bayer and Regeneron to Develop New Treatment Option for Wet Age-Related Macular Degeneration. Jan 15, 2014 414
China,United States : Eddingpharm ratifies asset purchase agreement with ACT Biotech. Jan 13, 2014 174
Opthea Signs Cell Line Development Commercial License Agreement with Selexis SA for Wet AMD Product. Jan 13, 2014 820
Revamped Therapies Preventing Visual Impairment Primed to Revolutionize US Retinal Therapeutics Market. Jan 8, 2014 1056
Revamped Therapies Preventing Visual Impairment Primed to Revolutionize US Retinal Therapeutics Market. Jan 8, 2014 1060
Analysis of the US Retinal Therapeutics Market. Jan 7, 2014 1318
Study shows YKL-40 biomarker may improve detection of mesothelioma. Dec 20, 2013 212
Aerobic exercise boosts memory in young adults. Dec 3, 2013 236
In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor. Dec 1, 2013 283
New technique could help block cancer growth. Nov 30, 2013 257
Germany : Data at 48 weeks for Phase 3 MYRROR trial in mCNV demonstrate long-term efficacy of VEGF Trap-Eye. Nov 19, 2013 232
Bayer HealthCare submits marketing authorisation application for VEGF Trap-Eye. Nov 11, 2013 141
Bayer HealthCare submits marketing authorisation application for VEGF Trap-Eye. Nov 11, 2013 137
CURIS & DEBIOPHARM BEGIN PHASE I DOSE FINDING STUDY. Nov 1, 2013 657
DSM and Opthea Sign Agreement to Manufacture Opthea's Lead Product for Eye Disease. Oct 29, 2013 1297
BAYER'S STIVARGA (REGORAFENIB) APPROVED IN THE EU. Oct 1, 2013 477
Study Published in Nature Biotechnology Demonstrates Ability of Moderna's Novel Therapeutic Paradigm to Repair and Regenerate Damaged Heart Tissue. Sep 8, 2013 1034
Significance of neuropilin-1 expression in acute myeloid leukemia / Ciddi, Direncli, Oldurucu, Kazanilmis Aplastik Aneminin Klinik Seyrine E Uygulamasinin Katkisi. Sallam, Tarif H.; Shams, Manal A.; El Telbany, Eldin; Mahmoud, Hanan M.; Iskander, Mutea A. Report Sep 1, 2013 4595
Gene expression of VEGF-A and VEGF-C in peripheral blood mononuclear cells of Iranian patients with acute myeloid leukemia / Akut Miyeloid Losemili iranli Hastalarin Periferik Kan Mononukleer Hucrelerinde VEGF-A ve VEGF-C Gen Ekspresyonu. A1iparasti, Mohammad Reza; A1masi, Shohreh; Sanaat, Zohreh; Movasaghpoor, Aliakbar; Khalili-Dizaji, Report Jun 1, 2013 4496
The anti-VEGF dilemma. Withers, Nikki May 17, 2013 1345
Oraya therapy reduces need for anti-VEGF. Withers, Nikki Brief article May 3, 2013 230
Artery formation after heart attack discovered. Apr 30, 2013 253
US study shows VEGF may not be efficient biomarker for advanced prostate cancer. Apr 30, 2013 261
Anaerobic glycosis is the centre of different biochemical disarrays associated with the onset of diabetic retinopathy. Mondal, Lakshmi Kanta; Choudhury, Subhojit; Paine, Suman Kalyan; Sen, Aditi; Bhaduri, Gautam; Bhatta Clinical report Apr 8, 2013 4178
Vascular Endothelial Growth Factor (VEGF) Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2013. Apr 2, 2013 676
Vascular Endothelial Growth Factor (VEGF) Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2013. Apr 2, 2013 682
Oraya Therapy[TM] Continues to Show Efficacy for Wet Age-Related Macular Degeneration. Feb 28, 2013 1069
Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis. Kimura, Yoshiyuki; Sumiyoshi, Maho Report Feb 15, 2013 6287
VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2013. Feb 5, 2013 1343
Germany : Bayer Submits VEGF Trap-Eye (aflibercept) for Treatment of Macular Edema Following Central Retinal Vein Occlusion in Japan. Jan 8, 2013 447
The effect of intravitreal bevacizumab on apoptosis of rat retina cells/Intravitreal bevacizumabm sican retina hucrelerinde apoptozis uzerine etkileri. Kayikcioglu, Ozcan; Vatansever, Seda; Topcu, Ismet; Aydemir, Isil; Bilecenoglu, Tugce; Kahvecioglu, Report Jan 1, 2013 4315
Study to assess the pathophysiological role of VEGF in patients with chronic myeloid leukemia (CML). Meena, L.P.; Prakash, J.; Tandon, R.; Bharti, Anju; Meena, V.K.; Tripathi, K. Report Jan 1, 2013 2536
Germany : Bayer Submits VEGF Trap-Eye (aflibercept) for Treatment of Macular Edema Following Central Retinal Vein Occlusion in EU. Dec 7, 2012 431
Xcovery's Dual VEGF/PDGFR Inhibitor, X-82 Named to 2012 Top Projects to Watch Hot Space List. Nov 30, 2012 1004
Caution over anti-VEGF use. Withers, Nikki Brief article Nov 2, 2012 271
Serum erythropoietin, insulin-like growth factor 1 and vascular endothelial growth factor in ethiopathogenesis of retinopathy of prematurity/Premature retinopatisi etyopatogenezinde serum eritropoetin, insulin benzeri buyume faktoru 1 ve vaskuler endotelyel buyume faktoru. Yenice, Ozlem; Ashour, Ahmed; Cerman, Eren; Firat, Ridvan; Haklar, Goncagul; Sirikci, Onder; Akman, Report Nov 1, 2012 3948
Pharmacological approach for treatment of retinopathy of prematurity /Premature retinopatisinde medikal tedavinin yeri. Akkoyun, Imren Report Nov 1, 2012 6255
Germany : VEGF Trap-Eye (aflibercept ophthalmic injection) Recommended for Approval for the Treatment of Wet Age-Related Macular Degeneration in Europe. Sep 22, 2012 447
Pfizer Receives EU Marketing Authorization for INLYTA[R] (Axitinib). Sep 4, 2012 1865
New economical gene therapy strategy promotes cardiac repair. Jul 8, 2012 381
Levels of serum vascular endothelial growth factor in Type 2 diabetics with retinopathy. Clinical report Jun 30, 2012 2976
Fucoidan extract derived from Undaria pinnatifida inhibits angiogenesis by human umbilical vein endothelial cells. Liu, Fang; Wang, Jia; Chang, Alan K.; Liu, Bing; Yang, Lili; Li, Qiaomei; Wang, Peisheng; Zou, Xiang Report Jun 15, 2012 5457

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters